[Skip to Content]
[Skip to Content Landing]
Viewpoint
December 5, 2017

Responsible Care in the Face of Shifting Recommendations and Imperfect Diagnostics for Zika Virus

Author Affiliations
  • 1Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Massachusetts General Hospital, Boston
  • 2Center for Bioethics and Department of Social Medicine, University of North Carolina at Chapel Hill
JAMA. 2017;318(21):2075-2076. doi:10.1001/jama.2017.15680

The US Centers for Disease Control and Prevention (CDC) recently released updated interim guidance for when pregnant women should receive serologic testing for the Zika virus.1 The circumstances within which these recommendations emerge are complex: the public concern about the Zika virus is declining, the severity of epidemics around the globe is abating, and as a critical consideration in the development of recommendations, the rate of false-positive Zika virus test results (and the consequential unnecessary anxiety) is high.

×